Portfolio News

SeeSense has partnered with Transport Accident Commission (TAC) Deakin University and iMOVE Australia to produce report findings and recommendations where their technology and data were used to understand cycling behaviour and derive road safety insights. The report states that already the data collected has provided“… a rich dataset for future research and analysis. The data is objective, and has […]

Established in 2011, GoReport identified a void in the market for software which helps surveyors digitise their inspecting, reporting and analysis process. GoReport provides software which support surveys and inspections in the residential and commercial sector and is used by a range of clients to support the transition towards digital workflows, enabling surveyors to focus

The new investment will support PlotBox‘s strategy for global growth and expansion, enabling its continued development of best-in-class products and services that will help to revolutionise the way deathcare facilities both operate and grow. Pictured above: Leona McAllister and Sean McAllister (Joint CEO’s) PlotBox, the leading software solutions provider to cemeteries and crematoria, has announced a

Congratulations to Helen McCarthy, Darach Neeson, and the rest of the pHion Therapeutics team, as well as Ben Toogood at invoX Pharma Limited. We look forward to continuing to support the company, along with QUBIS Ltd and other investors, on its exciting growth journey. Article taken from: https://finance.yahoo.com/ LONDON, June 01, 2023–(BUSINESS WIRE)–invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-stage Alzheimer’s Dementia Validation Trial. Article taken from: https://cumulusneuro.com/articles/2023_05_31/ We are pleased to announce the completion of patient enrollment for our CNS-101 multi-site study. The real-world study evaluates the feasibility of using repeated sampling of validated digital measures at home in patients with early-stage Alzheimer’s disease (AD), compared with

Investment success for Belfast-based GenoME Diagnostics to support further development of its novel testing technology. Article taken from: https://startacus.net/ Belfast-based cancer diagnostics company GenoME Diagnostics has closed a £1.4 million funding round which will be used to further develop its lead product OvaME, a novel blood test for earlier and more accurate detection of ovarian cancer. The

A number of our portfolio companies have been nominated in the Insider Media Northern Ireland Dealmaker Awards: Private Equity / Venture Capital Deal of the Year– Re-Vana Therapeutics Deal of the Year (sub £2.5m)– Kinsetsu– ANGOKA– Tribe Tech Group– WE ARE PARADOXX– pitchbooking.com Deal of the Year (£2.5m – £10m)– CV6 Therapeutics, (NI) Ltd.– Axial3D Big congratulations to all of the above nominees and best

This landmark deal for Co-Fund NI means that it has now deployed capital of £43m, which has helped to leverage £285m of private investment into the Northern Ireland economy, since its inception in 2011. Article taken from: https://www.irishnews.com/ Pictured above (from left) Joanne O’Doherty, chief executive at Kinsetsu; Brian Cummings, investment director, Clarendon Fund Managers;

One of Queen’s technology spin-out companies, Re-Vana Therapeutics, has attracted £10m of investment for research into sight-threatening eye disease. Article taken from: https://www.qub.ac.uk/News/ Pictured L-R are: Re-Vana Co-Founder, Professor Raj Thakur; QUBIS CEO, Brian McCaul; and Re-Vana Co-Founder and Queen’s University Pro-Vice-Chancellor, Professor David Jones. The company’s innovative method of sustained-release therapeutics can replace regular

Article taken from: https://www.lifearc.org/ Headquartered in London, Surgery Hero is a digital clinic that helps people prepare for and recover from surgery at home. The £2 million of seed funding will be used to scale their solution to be able to support more people undergoing surgery, as they begin their expansion to the US where